NutriDex

The Supplement Research Compendium
🥤

Aspartame

E951

The most-studied artificial sweetener — reassuring at intake limits, with a contested cancer signal

Mixed evidence 🍬Sweeteners & Additives

✚ Updated · How we grade evidence

Evidence tier
Mixed
Research weight
Citations
7 verified / 7
Classification
Sweeteners & Additives
❝
What the evidence says. Conflicting results across studies; benefit uncertain.

What is Aspartame?

Aspartame (E951) is a sweetener or food additive used for intense sweetness ~200x sucrose, so tiny amounts sweeten foods. NutriDex grades the human evidence as Mixed. Aspartame (E951) is a low-calorie, high-intensity sweetener about 200x sweeter than sucrose, made of aspartic acid and phenylalanine joined as a methyl ester. It is one of the most extensively studied food additives and is approved worldwide — by the FDA (since 1974), EFSA, and JECFA — for use in diet sodas, tabletop sweeteners, sugar-free gum, yogurt and many "light"/"zero" products. Major regulators conclude it is safe within the Acceptable Daily Intake; however, IARC classified it Group 2B "possibly carcinogenic" in 2023 (limited human evidence for liver cancer), and some large cohorts report weak associations with cancer and cardiometabolic outcomes, so the weight of human evidence is best described as reassuring at typical intakes but mixed on long-term risk.

Purported Benefits

✓Intense sweetness ~200x sucrose, so tiny amounts sweeten foods
✓Effectively zero-calorie at use levels (it is metabolized but used in trace amounts)
✓Minimal to no acute glycemic or insulin impact in human trials — suitable as a sugar substitute for people with diabetes
✓Does not promote tooth decay (non-cariogenic)
✓Used to reformulate sugar-sweetened beverages and foods to cut added sugar and calories

Dosing & Compounds

Typical Dose
FDA ADI 50 mg/kg body weight/day (approved as a food additive, not GRAS); EFSA and JECFA/WHO ADI 40 mg/kg bw/day. JECFA reaffirmed the 40 mg/kg ADI in 2023. A 70 kg adult would need roughly 9-14 cans of diet soda daily to exceed the ADI. Must be avoided by people with phenylketonuria (PKU) due to its phenylalanine content.
Active Compounds
E-number: E951Brand names: NutraSweet, Equal, Canderel, AminoSweetDiet/zero sodas (e.g., Diet Coke, Diet Pepsi), often blended with acesulfame-KSugar-free chewing gum, tabletop sweetener packets, light yogurts, sugar-free desserts and drink mixes, some chewable medicines/vitaminsUS labels must carry: 'Phenylketonurics: Contains Phenylalanine'

Safety & Cautions

For the general population, FDA, EFSA and JECFA judge aspartame safe at the ADI, and EFSA (2013) found no evidence of genotoxicity, carcinogenicity, or harm to the brain, behavior, pregnancy, or children at intakes up to the ADI. The notable signals: IARC classified aspartame Group 2B "possibly carcinogenic to humans" in 2023 based on limited evidence for hepatocellular (liver) carcinoma, while JECFA simultaneously retained the 40 mg/kg ADI, finding the cancer association unconvincing. Observational data are mixed — the NutriNet-Santé cohort linked higher aspartame intake to modestly increased breast and obesity-related cancers (small effect sizes, residual confounding likely). The WHO's 2023 guideline advises against non-sugar sweeteners for weight control, citing no long-term benefit and possible associations with type 2 diabetes and cardiovascular risk (low-certainty evidence). People with PKU must avoid it because they cannot metabolize phenylalanine; claims of headaches, seizures, or neurotoxicity at normal intakes are not supported by controlled evidence. Educational only — always check with your doctor or pharmacist before combining Aspartame with any medicine.

Key Studies

meta-analysis Systematic review & meta-analysis 2025 (Advances in Nutrition) ✓ PubMed
Across 100 experiments, aspartame had few effects on blood glucose, insulin, or appetite hormones versus controls and lowered them versus sugars; certainty of evidence very low.
regulatory IARC/WHO 2023 ✓ Source
Classified aspartame Group 2B 'possibly carcinogenic to humans' on limited evidence for hepatocellular carcinoma, while JECFA reaffirmed the 0-40 mg/kg bw/day ADI.
regulatory US FDA ✓ Source
Approved aspartame as a sweetener (first 1974); maintains an ADI of 50 mg/kg bw/day and requires a phenylalanine warning for people with PKU.
guideline WHO guideline 2023 ✓ Source
Advises against using non-sugar sweeteners (including aspartame) for weight control, citing no long-term body-fat benefit and possible associations with type 2 diabetes and cardiovascular disease (low-certainty evidence).
regulatory IARC Summary of Findings 2023 ✓ Source
Detailed monograph rationale: limited evidence in humans (liver cancer), limited evidence in experimental animals, and limited mechanistic evidence supported the Group 2B classification.
regulatory EFSA ANS Panel 2013 ✓ Source
Full re-evaluation concluded aspartame is safe at current exposure, ruling out genotoxicity and carcinogenicity, with ADI of 40 mg/kg bw/day protective for the general population including children and pregnant women.
cohort Debras/Touvier (NutriNet-Santé) 2022 ✓ Source
In 102,865 French adults, higher aspartame intake was associated with increased breast cancer (HR 1.22, 95% CI 1.01-1.48) and obesity-related cancers (HR 1.15, 95% CI 1.01-1.32).
7 sources cited · 7 verified Search all studies on PubMed ↗

Common questions about Aspartame

What is Aspartame used for?

Aspartame is most often taken for Intense sweetness ~200x sucrose, so tiny amounts sweeten foods, Effectively zero-calorie at use levels (it is metabolized but used in trace amounts), Minimal to no acute glycemic or insulin impact in human trials — suitable as a sugar substitute for people with diabetes, Does not promote tooth decay (non-cariogenic). The most-studied artificial sweetener — reassuring at intake limits, with a contested cancer signal

Does Aspartame work — what does the evidence say?

Mixed evidence. Conflicting results across studies; benefit uncertain. Aspartame (E951) is a low-calorie, high-intensity sweetener about 200x sweeter than sucrose, made of aspartic acid and phenylalanine joined as a methyl ester. It is one of the most extensively studied food additives and is approved worldwide — by the FDA (since 1974), EFSA, and JECFA — for use in diet sodas, tabletop sweeteners, sugar-free gum, yogurt and many "light"/"zero" products. Major regulators conclude it is safe within the Acceptable Daily Intake; however, IARC classified it Group 2B "possibly carcinogenic" in 2023 (limited human evidence for liver cancer), and some large cohorts report weak associations with cancer and cardiometabolic outcomes, so the weight of human evidence is best described as reassuring at typical intakes but mixed on long-term risk.

What is the typical dose of Aspartame?

FDA ADI 50 mg/kg body weight/day (approved as a food additive, not GRAS); EFSA and JECFA/WHO ADI 40 mg/kg bw/day. JECFA reaffirmed the 40 mg/kg ADI in 2023. A 70 kg adult would need roughly 9-14 cans of diet soda daily to exceed the ADI. Must be avoided by people with phenylketonuria (PKU) due to its phenylalanine content.

Is Aspartame safe? Any cautions or side effects?

For the general population, FDA, EFSA and JECFA judge aspartame safe at the ADI, and EFSA (2013) found no evidence of genotoxicity, carcinogenicity, or harm to the brain, behavior, pregnancy, or children at intakes up to the ADI. The notable signals: IARC classified aspartame Group 2B "possibly carcinogenic to humans" in 2023 based on limited evidence for hepatocellular (liver) carcinoma, while JECFA simultaneously retained the 40 mg/kg ADI, finding the cancer association unconvincing. Observational data are mixed — the NutriNet-Santé cohort linked higher aspartame intake to modestly increased breast and obesity-related cancers (small effect sizes, residual confounding likely). The WHO's 2023 guideline advises against non-sugar sweeteners for weight control, citing no long-term benefit and possible associations with type 2 diabetes and cardiovascular risk (low-certainty evidence). People with PKU must avoid it because they cannot metabolize phenylalanine; claims of headaches, seizures, or neurotoxicity at normal intakes are not supported by controlled evidence.

How many studies support Aspartame?

NutriDex cites 7 sources for Aspartame, graded "Mixed".

Cite this page
APA

Peh, D. (2026). Aspartame (E951): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/aspartame

BibTeX
@misc{nutridex_aspartame,
  author       = {Peh, Daryl},
  title        = {Aspartame (E951): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/aspartame},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances